Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2025
- QYR2463182
- 106 Pages
- February 2018
- Medical Devices
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can be split into
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
Market segment by Application, Next Generation Cancer Diagnostics can be split into
Hospitals
Clinics
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2025
1 Industry Overview of Next Generation Cancer Diagnostics
1.1 Next Generation Cancer Diagnostics Market Overview
1.1.1 Next Generation Cancer Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Cancer Diagnostics Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Next Generation Cancer Diagnostics Market by Type
1.3.1 Next Generation Sequencing
1.3.2 qPCR & Multiplexing
1.3.3 DNA Microarrays
1.3.4 Other
1.4 Next Generation Cancer Diagnostics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other
2 Global Next Generation Cancer Diagnostics Competition Analysis by Players
2.1 Next Generation Cancer Diagnostics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Cepheid
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Koninklijke Philips N.V
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Qiagen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Abbott
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Thermo Fisher Scientific
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Opko Health
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments
3.9 Myriad Genetics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.9.5 Recent Developments
3.10 Agilent Technologies
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Cancer Diagnostics Revenue (Million USD) (2013-2018)
3.10.5 Recent Developments
3.11 GE Healthcare
3.12 PerkinElmer
3.13 Genomic Health
3.14 Illumina
3.15 Hologic
3.16 Almac Group
3.17 Janssen Global Services
3.18 Sysmex Corporation
4 Global Next Generation Cancer Diagnostics Market Size by Type and Application (2013-2018)
4.1 Global Next Generation Cancer Diagnostics Market Size by Type (2013-2018)
4.2 Global Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
4.3 Potential Application of Next Generation Cancer Diagnostics in Future
4.4 Top Consumer/End Users of Next Generation Cancer Diagnostics
5 United States Next Generation Cancer Diagnostics Development Status and Outlook
5.1 United States Next Generation Cancer Diagnostics Market Size (2013-2018)
5.2 United States Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
5.3 United States Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
6 EU Next Generation Cancer Diagnostics Development Status and Outlook
6.1 EU Next Generation Cancer Diagnostics Market Size (2013-2018)
6.2 EU Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
6.3 EU Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
7 Japan Next Generation Cancer Diagnostics Development Status and Outlook
7.1 Japan Next Generation Cancer Diagnostics Market Size (2013-2018)
7.2 Japan Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
7.3 Japan Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
8 China Next Generation Cancer Diagnostics Development Status and Outlook
8.1 China Next Generation Cancer Diagnostics Market Size (2013-2018)
8.2 China Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
8.3 China Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
9 India Next Generation Cancer Diagnostics Development Status and Outlook
9.1 India Next Generation Cancer Diagnostics Market Size (2013-2018)
9.2 India Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
9.3 India Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
10 Southeast Asia Next Generation Cancer Diagnostics Development Status and Outlook
10.1 Southeast Asia Next Generation Cancer Diagnostics Market Size (2013-2018)
10.2 Southeast Asia Next Generation Cancer Diagnostics Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Next Generation Cancer Diagnostics Market Size (Value) by Regions (2018-2025)
11.1.1 United States Next Generation Cancer Diagnostics Revenue and Growth Rate (2018-2025)
11.1.2 EU Next Generation Cancer Diagnostics Revenue and Growth Rate (2018-2025)
11.1.3 Japan Next Generation Cancer Diagnostics Revenue and Growth Rate (2018-2025)
11.1.4 China Next Generation Cancer Diagnostics Revenue and Growth Rate (2018-2025)
11.1.5 India Next Generation Cancer Diagnostics Revenue and Growth Rate (2018-2025)
11.1.6 Southeast Asia Next Generation Cancer Diagnostics Revenue and Growth Rate (2018-2025)
11.2 Global Next Generation Cancer Diagnostics Market Size (Value) by Type (2018-2025)
11.3 Global Next Generation Cancer Diagnostics Market Size by Application (2018-2025)
12 Next Generation Cancer Diagnostics Market Dynamics
12.1 Next Generation Cancer Diagnostics Market Opportunities
12.2 Next Generation Cancer Diagnostics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Next Generation Cancer Diagnostics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Next Generation Cancer Diagnostics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Next Generation Cancer Diagnostics Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Next Generation Cancer Diagnostics Market Share by Regions (2013-2018)
Figure United States Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Next Generation Cancer Diagnostics Revenue Market Share by Type in 2017
Figure Next Generation Sequencing Market Size (Million USD) and Growth Rate (2013-2018)
Figure qPCR & Multiplexing Market Size (Million USD) and Growth Rate (2013-2018)
Figure DNA Microarrays Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Next Generation Cancer Diagnostics Market Share by Application in 2017
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table Cepheid Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Cepheid (2013-2018)
Figure Cepheid Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Koninklijke Philips N.V Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Koninklijke Philips N.V (2013-2018)
Figure Koninklijke Philips N.V Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd (2013-2018)
Figure F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Qiagen Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Qiagen (2013-2018)
Figure Qiagen Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Novartis AG (2013-2018)
Figure Novartis AG Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Abbott Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Abbott (2013-2018)
Figure Abbott Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Thermo Fisher Scientific Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Thermo Fisher Scientific (2013-2018)
Figure Thermo Fisher Scientific Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Opko Health Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Opko Health (2013-2018)
Figure Opko Health Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Myriad Genetics Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Myriad Genetics (2013-2018)
Figure Myriad Genetics Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Agilent Technologies Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Agilent Technologies (2013-2018)
Figure Agilent Technologies Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table GE Healthcare Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of GE Healthcare (2013-2018)
Figure GE Healthcare Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table PerkinElmer Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of PerkinElmer (2013-2018)
Figure PerkinElmer Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Genomic Health Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Genomic Health (2013-2018)
Figure Genomic Health Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Illumina Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Illumina (2013-2018)
Figure Illumina Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Hologic Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Hologic (2013-2018)
Figure Hologic Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Almac Group Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Almac Group (2013-2018)
Figure Almac Group Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Janssen Global Services Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Janssen Global Services (2013-2018)
Figure Janssen Global Services Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Sysmex Corporation Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Sysmex Corporation (2013-2018)
Figure Sysmex Corporation Next Generation Cancer Diagnostics Business Revenue Market Share (2013-2018)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Product (2013-2018)
Figure Global Next Generation Cancer Diagnostics Revenue Market Share (%) by Product (2013-2018)
Figure Global Next Generation Cancer Diagnostics Market Share by Product in 2017
Table Global Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure Global Next Generation Cancer Diagnostics Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Next Generation Cancer Diagnostics
Figure United States Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure United States Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure United States Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table United States Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure United States Next Generation Cancer Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure United States Next Generation Cancer Diagnostics Market Size Share by Application in 2017
Figure EU Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure EU Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure EU Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table EU Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure EU Next Generation Cancer Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure EU Next Generation Cancer Diagnostics Market Size Share by Application in 2017
Figure Japan Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table Japan Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure Japan Next Generation Cancer Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Application in 2017
Figure China Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate (2013-2018)
Table China Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure China Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure China Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table China Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure China Next Generation Cancer Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure China Next Generation Cancer Diagnostics Market Size Share by Application in 2017
Figure India Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate (2013-2018)
Table India Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure India Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure India Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table India Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure India Next Generation Cancer Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure India Next Generation Cancer Diagnostics Market Size Share by Application in 2017
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Players in 2013
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table Southeast Asia Next Generation Cancer Diagnostics Market Size by Application (2013-2018)
Figure Southeast Asia Next Generation Cancer Diagnostics Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Application in 2017
Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate (2018-2025)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Regions (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size Share (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions in 2025
Figure United States Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Type (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2018
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2025
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application (2018-2025)
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2018
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2025
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
